Investigation Report on China's Gliclazide Market, 2018-2022

Publisher Name :
Date: 14-Sep-2018
No. of pages: 30

Description

The overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end of 2017, and is still rising.

Taken by mouth, Gliclazide is a second-generation sulfonylurea to treat diabetes by stimulating insulin secretion from pancreatic ?-cells. It can protect pancreatic ?-cells from the apoptosis caused by hyperglycemia, and prevent atherosclerosis (build-up of fatty deposits in the arteries) caused by type 2 diabetes.

Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and entered China in the 1980s. In China, at least 200,000 people with type 2 diabetes are taking Gliclazide every year.

In 1987, Tianjin Huajin Pharmaceutical Factory (now known as Tianjin Huajin Pharmaceutical Co., Ltd.) started cooperating with Servier and Tianjin Pharmaceutical Station to produce Gliclazide (Diamicron), a new drug to treat type 2 diabetes. With the support of Servier, the company has been taking the leading position on China's Gliclazide market. Also dominating the market are Servier and Servier (Tianjin) Pharmaceutical Co., Ltd., the joint venture of Servier and Tianjin Huajin Pharmaceutical Co., Ltd.

According to CRI, the sales value of Gliclazide kept rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China's Gliclazide market will continue to grow as the incidence of type 2 diabetes rises.

Investigation Report on China's Gliclazide Market, 2018-2022

Table of Contents
1 Relevant Concepts of Gliclazide
1.1 Indications for Gliclazide
1.2 Development History of Gliclazide in China
1.3 Governmental Approval of Gliclazide in China

2 Sales of Gliclazide in China, 2013-2017
2.1 Sales Value
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Gliclazide by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 Analysis on Major Gliclazide Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Gliclazide Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Servier
3.2.1 Enterprise Profile
3.2.2 Sales of Servier's Gliclazide in China
3.3 Servier (Tianjin) Pharmaceutical Co., Ltd.
3.4 Tianjin Huajin Pharmaceutical Co. Ltd.
3.5 Nanchang Helioeast Pharmaceutical Co., Ltd.
3.6 Guilin Hwasun Pharmaceutical Co., Ltd.

4 Prices of Gliclazide in China, 2017-2018
4.1 Servier (Diamicron)
4.2 Servier (Tianjin) Pharmaceutical Co., Ltd. (Diamicron)
4.3 Tianjin Huajin Pharmaceutical Co. Ltd. (Diamicron)
4.4 Nanchang Helioeast Pharmaceutical Co., Ltd. (Hongxuyang)
4.5 Guilin Hwasun Pharmaceutical Co., Ltd. (Xieerping)

5 Prospect of China's Gliclazide Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

Selected Charts
Chart Sales of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide in Parts of China, 2013-2017
Chart Sales Volume of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide Tablets in China, 2013-2017
Chart Sales Value of Gliclazide Capsules in China, 2013-2017
Chart Market Share of Top 5 Gliclazide Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Servier
Chart Sales Value of Servier's Gliclazide in China, 2013-2017
Chart Sales Value of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in China, 2013-2017
Chart Sales Value of Servier Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in China, 2013-2017
Chart Prices of Servier's Gliclazide in Parts of China, 2017-2018
Chart Prices of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Prices of Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Governmental Approval of Gliclazide in China
Chart Forecast on Sales Value of Gliclazide in China, 2018-2012
  • Global Lixisenatide Market Insights, Forecast to 2025
    Published: 13-Sep-2018        Price: US 3900 Onwards        Pages: 115
    This report studies the global market size of Lixisenatide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lixisenatide in these regions. This research report categorizes the global Lixisenatide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and cha......
  • Global Antidiabetic Thiazolidinediones Market Insights, Forecast to 2025
    Published: 13-Sep-2018        Price: US 3900 Onwards        Pages: 113
    This report studies the global market size of Antidiabetic Thiazolidinediones in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidiabetic Thiazolidinediones in these regions. This research report categorizes the global Antidiabetic Thiazolidinediones market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth r......
  • Global Antidiabetic Biguanides Market Insights, Forecast to 2025
    Published: 12-Sep-2018        Price: US 3900 Onwards        Pages: 117
    This report studies the global market size of Antidiabetic Biguanides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidiabetic Biguanides in these regions. This research report categorizes the global Antidiabetic Biguanides market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global Antidiabetic Sulphonylureas Market Insights, Forecast to 2025
    Published: 12-Sep-2018        Price: US 3900 Onwards        Pages: 117
    This report studies the global market size of Antidiabetic Sulphonylureas in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidiabetic Sulphonylureas in these regions. This research report categorizes the global Antidiabetic Sulphonylureas market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future ......
  • Global Antidiabetic SGLT-2 Inhibitor Market Insights, Forecast to 2025
    Published: 12-Sep-2018        Price: US 3900 Onwards        Pages: 117
    This report studies the global market size of Antidiabetic SGLT-2 Inhibitor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidiabetic SGLT-2 Inhibitor in these regions. This research report categorizes the global Antidiabetic SGLT-2 Inhibitor market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • 2018-2023 UK Glucagon Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 85
    In 2017, the Glucagon market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - Novo Nordisk - Eli Lilly - Fresenius Kabi - Torrent Labs - Taj Pharmaceuticals - Xeris Pharmaceuticals Split by product types/category, covering - Inject Glucagon - Nasal Glucagon Split by applications/end use industri......
  • 2018-2023 United States Glucagon Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 85
    In 2017, the Glucagon market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Novo Nordisk - Eli Lilly - Fresenius Kabi - Torrent Labs - Taj Pharmaceuticals - Xeris Pharmaceuticals Split by product types/category, covering - Inject Glucagon - Nasal Glucagon Split by applica......
  • 2018-2023 India Glucagon Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 85
    In 2017, the Glucagon market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Novo Nordisk - Eli Lilly - Fresenius Kabi - Torrent Labs - Taj Pharmaceuticals - Xeris Pharmaceuticals Split by product types/category, covering - Inject Glucagon - Nasal Glucagon Split by applications/end use in......
  • 2018-2023 Philippines Glucagon Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 85
    In 2017, the Glucagon market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Novo Nordisk - Eli Lilly - Fresenius Kabi - Torrent Labs - Taj Pharmaceuticals - Xeris Pharmaceuticals Split by product types/category, covering - Inject Glucagon - Nasal Glucagon Split by application......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs